89bio, Inc. (ETNB) DCF Valuation

89bio, Inc. (ETNB) DCF Valuation

US | Healthcare | Biotechnology | NASDAQ
89bio, Inc. (ETNB) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

89bio, Inc. (ETNB) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Whether you're an investor or analyst, this (ETNB) DCF Calculator is your go-to tool for accurate valuation. Loaded with real data from 89bio, Inc., you can adjust forecasts and observe the effects in real-time.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -57.2 -49.5 -90.2 -99.8 -134.5 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .0 .1 .1 .2 .3 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -57.2 -49.6 -90.3 -100.1 -134.7 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 93.4 204.7 150.7 188.2 578.9 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable 1.0 2.1 6.8 12.5 8.6 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure -.1 -.1 -.1 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % -2.8 -2.8 -2.8 -2.8 -2.8 -2.8 -2.8 -2.8 -2.8 -2.8
EBITAT -57.4 -49.5 -90.1 -100.1 -138.5 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -56.6 -48.5 -85.3 -94.2 -142.2 -8.6 .0 .0 .0 .0
WACC, % 9.26 9.26 9.26 9.26 9.26 9.26 9.26 9.26 9.26 9.26
PV UFCF
SUM PV UFCF -7.9
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -8
Net Debt -289
Equity Value 281
Diluted Shares Outstanding, MM 71
Equity Value Per Share 3.95

What You Will Get

  • Real 89bio Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures.
  • Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • Instant Valuation Updates: Automatic recalculations to analyze the impact of changes on 89bio’s fair value.
  • Versatile Excel Template: Tailored for quick edits, scenario testing, and detailed projections.
  • Time-Saving and Accurate: Skip building models from scratch while maintaining precision and flexibility.

Key Features

  • Pre-Loaded Data: 89bio, Inc.'s (ETNB) historical financial statements and pre-filled forecasts.
  • Fully Adjustable Inputs: Modify WACC, tax rates, revenue growth, and EBITDA margins as needed.
  • Instant Results: View 89bio, Inc.'s (ETNB) intrinsic value recalculating in real time.
  • Clear Visual Outputs: Dashboard charts present valuation results and essential metrics.
  • Built for Accuracy: A professional tool designed for analysts, investors, and finance professionals.

How It Works

  • Step 1: Download the prebuilt Excel template featuring 89bio, Inc.'s (ETNB) data.
  • Step 2: Navigate through the pre-filled sheets to familiarize yourself with the essential metrics.
  • Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
  • Step 4: Immediately see the recalculated results, including 89bio, Inc.'s (ETNB) intrinsic value.
  • Step 5: Use the outputs to make informed investment decisions or create detailed reports.

Why Choose This Calculator for 89bio, Inc. (ETNB)?

  • Comprehensive Tool: Integrates DCF, WACC, and financial ratio analyses all in one solution.
  • Customizable Inputs: Modify yellow-highlighted cells to explore different financial scenarios.
  • Detailed Insights: Automatically computes 89bio, Inc.'s intrinsic value and Net Present Value.
  • Preloaded Data: Access to historical and projected data for reliable starting points.
  • Professional Quality: Perfect for financial analysts, investors, and business advisors.

Who Should Use This Product?

  • Professional Investors: Develop comprehensive and accurate valuation models for portfolio assessments related to 89bio, Inc. (ETNB).
  • Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within their organizations concerning 89bio, Inc. (ETNB).
  • Consultants and Advisors: Deliver precise valuation insights for clients interested in 89bio, Inc. (ETNB) stock.
  • Students and Educators: Leverage real-world data to enhance learning and practice in financial modeling with a focus on 89bio, Inc. (ETNB).
  • Biotech Enthusiasts: Gain insights into the valuation processes of biotech firms like 89bio, Inc. (ETNB) in the market.

What the Template Contains

  • Preloaded ETNB Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
  • DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
  • Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
  • Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
  • Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
  • Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.

No products were found matching.